Groupe Renault : Communication of Groupe Renault June 6, 2019

PRESS RELEASE                                                                                                       2019/06/06

Communication of Groupe Renault

Boulogne-Billancourt, June 6^th, 2019 – Groupe Renault expresses its disappointment not to have the opportunity to continue to pursue the proposal of FCA (Fiat Chrysler Automobiles).

We are gratified by the constructive approach of Nissan and wish to thank FCA for their efforts and the Renault’s Board of Directors for its continued confidence.

We view the opportunity as timely, having compelling industrial logic and great financial merit, and which would result in a European based global auto powerhouse.

Further, we believe it emphasises the attractivess of Renault and of the Alliance.

***

About Groupe Renault

Groupe Renault has manufactured cars since 1898. Today it is an international multi-brand group, selling close to 3.9 million vehicles in 134 countries in 2018, with 36 manufacturing sites, 12,700 points of sales and employing more than 180,000 people.
To address the major technological challenges of the future, while continuing to pursue its profitable growth strategy, Groupe Renault is focusing on international expansion. To this end, it is drawing on the synergies of its five brands (Renault, Dacia, Renault Samsung Motors, Alpine and LADA), electric vehicles, and its unique alliance with Nissan and Mitsubishi Motors. With a 100% Renault owned team committed to the Formula 1 World Championship since 2016, the brand is involved in motorsports, a real vector for innovation and awareness.

For more information:

Frédéric TEXIER
Head of Media Relations
+33 (0)1 76 84 33 67
+33 (0) 6 10 78 49 20
[email protected]

GROUPE RENAULT
MEDIA OFFICE
Tel.: +33 (0) 1 76 84 63 36
[email protected] 

Sites web: www.media.renault.com - www.group.renault.com

Attachment

• CP Groupe Renault_06062019_ENG

You May Also Be Interested In

• Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
• Top Meme Coin To Buy: Pipedog Selling Persists Despite 3,294% APY as AlphaPepe Stage 20 Keeps Filling
• Endeavour Silver Announces Removal of Blockade at its Terronera Mine